Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim in refractory/ineligible aplastic anemia
NCT02773290Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2016
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of romiplostim in aplastic anemia, sponsored by Kyowa Kirin. Started May 2016; status: completed.
02
Drugs
romiplostim
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02773290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773290.